IVVD
Invivyd Inc.
NASDAQ: IVVD · HEALTHCARE · BIOTECHNOLOGY
$1.40
+2.94% today
Updated 2026-04-30
Market cap
$412.89M
P/E ratio
—
P/S ratio
7.73x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $3
Volume
2.8M
Invivyd Inc. (IVVD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-14.57M | $-184.74M | $-219.99M | $-173.16M | $-170.49M | $-58.13M |
| Capital expenditures | $84000.00 | $84000.00 | $1.71M | $615000.00 | $140000.00 | $155000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $265.00 | $17.76M | $21.65M | $18.68M | $19.79M | $11.64M |
| Free cash flow | $-14.65M | $-184.82M | $-221.69M | $-173.78M | $-170.63M | $-58.29M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | $-450.15M | — | — | — |